CSF1 and cytomegalovirus infection: The M‐CSF prophylaxis described by us targets NK cells and pDCs, whose protective functions during CMV infection are well described both in mice (Alexandre et al, 2014; Brinkmann et al, 2015) as well as in humans (Brinkmann et al, 2015).